4
Changes in Ownership
KALA BIO, Inc. Filed Acc 0001415889-24-000769
CHIEF EXECUTIVE OFFICER sold 4,539 shares at $6.73 ($30,547)
- CHIEF EXECUTIVE OFFICER acquired 14,300 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Iwicki Mark T CHIEF EXECUTIVE OFFICER | 2024-01-04 | Grant or award | +14,300 | 290,854 | D: show line 1 in the form | ||
| Iwicki Mark T CHIEF EXECUTIVE OFFICER | 2024-01-04 | Sale | −4,539 | $6.73 | $30,547 | 286,315 | D: show line 2 in the form |
| Open-market sales · 4,539 sh · avg $6.73 · $30,547 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Iwicki Mark T CHIEF EXECUTIVE OFFICER | 2024-01-04 | Grant or award · Stock Option (right to buy) | +64,500 | 64,500 | D: show line 3 in the form |
Loading xslF345X05/form4-01052024_090140.xml…